Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Biochemical and Molecular Toxicology|July 17, 2021
Protective effect of valsartan against doxorubicin-induced cardiotoxicity: Histopathology and metabolomics in vivo studyKhalid Alhazzani, Moureq R Alotaibi, Faisal N Alotaibi, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
The Potential Protective Role of Naringenin against Dasatinib-Induced HepatotoxicityAhmed Z Alanazi, Khalid Alhazzani, Salah Q Alrewily, et al.
Metabolites|February 25, 2022
Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use DisorderFawaz Alasmari, Mohammed A Assiri, Syed Rizwan Ahamad, et al.
Human & Experimental Toxicology|July 11, 2023
Hydroxychloroquine ameliorates dasatinib-induced liver injury via decrease in hepatic lymphocytes infiltrationKhalid Alhazzani, Salah Q Alrewily, Khaldoon Aljerian, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|June 4, 2026
TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanomaHomood M As Sobeai, Ali Hanbashi, Lama Binobaid, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|February 8, 2024
The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal modelHussain N Alhamami, Abdullah M Albogami, Mohammad M Algahtani, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|September 27, 2022
Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat modelWael A Alanazi, Hussain N Alhamami, Metab Alharbi, et al.
Pageof 8